1,701
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Medicaid best price reforms to enable innovative payment models for cell and gene therapies

, , , &
Pages 191-203 | Received 21 Nov 2022, Accepted 14 Dec 2022, Published online: 29 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sabine Vogler, Maximilian Salcher-Konrad & Katharina Habimana. (2023) Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 867-878.
Read now
Casey Quinn, Michael Ciarametaro, Brian Sils, Sharon Phares & Mark R. Trusheim. (2023) Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms. Expert Review of Pharmacoeconomics & Outcomes Research 23:5, pages 535-546.
Read now